Cargando…

Upper Gastrointestinal Cancer and Liver Cirrhosis

SIMPLE SUMMARY: There is a higher incidence rate of upper gastrointestinal cancer in those with liver cirrhosis. The contributing factors include gastric ulcers, congestive gastropathy, zinc deficiency, alcohol drinking, tobacco use and gut microbiota. Most of the de novo malignancies that develop a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeng, Kuo-Shyang, Chang, Chiung-Fang, Sheen, I-Shyan, Jeng, Chi-Juei, Wang, Chih-Hsuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105927/
https://www.ncbi.nlm.nih.gov/pubmed/35565397
http://dx.doi.org/10.3390/cancers14092269
_version_ 1784708157350608896
author Jeng, Kuo-Shyang
Chang, Chiung-Fang
Sheen, I-Shyan
Jeng, Chi-Juei
Wang, Chih-Hsuan
author_facet Jeng, Kuo-Shyang
Chang, Chiung-Fang
Sheen, I-Shyan
Jeng, Chi-Juei
Wang, Chih-Hsuan
author_sort Jeng, Kuo-Shyang
collection PubMed
description SIMPLE SUMMARY: There is a higher incidence rate of upper gastrointestinal cancer in those with liver cirrhosis. The contributing factors include gastric ulcers, congestive gastropathy, zinc deficiency, alcohol drinking, tobacco use and gut microbiota. Most of the de novo malignancies that develop after liver transplantation for cirrhotic patients are upper gastrointestinal cancers. The surgical risk of upper gastrointestinal cancers in cirrhotic patients with advanced liver cirrhosis is higher. ABSTRACT: The extended scope of upper gastrointestinal cancer can include esophageal cancer, gastric cancer and pancreatic cancer. A higher incidence rate of gastric cancer and esophageal cancer in patients with liver cirrhosis has been reported. It is attributable to four possible causes which exist in cirrhotic patients, including a higher prevalence of gastric ulcers and congestive gastropathy, zinc deficiency, alcohol drinking and tobacco use and coexisting gut microbiota. Helicobacter pylori infection enhances the development of gastric cancer. In addition, Helicobacter pylori, Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans also contribute to the development of pancreatic cancer in cirrhotic patients. Cirrhotic patients (especially those with alcoholic liver cirrhosis) who undergo liver transplantation have a higher overall risk of developing de novo malignancies. Most de novo malignancies are upper gastrointestinal malignancies. The prognosis is usually poor. Considering the surgical risk of upper gastrointestinal cancer among those with liver cirrhosis, a radical gastrectomy with D1 or D2 lymph node dissection can be undertaken in Child class A patients. D1 lymph node dissection can be performed in Child class B patients. Endoscopic submucosal dissection for gastric cancer or esophageal cancer can be undertaken safely in selected cirrhotic patients. In Child class C patients, a radical gastrectomy is potentially fatal. Pancreatic radical surgery should be avoided in those with liver cirrhosis with Child class B or a MELD score over 15. The current review focuses on the recent reports on some factors in liver cirrhosis that contribute to the development of upper gastrointestinal cancer. Quitting alcohol drinking and tobacco use is important. How to decrease the risk of the development of gastrointestinal cancer in those with liver cirrhosis remains a challenging problem.
format Online
Article
Text
id pubmed-9105927
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91059272022-05-14 Upper Gastrointestinal Cancer and Liver Cirrhosis Jeng, Kuo-Shyang Chang, Chiung-Fang Sheen, I-Shyan Jeng, Chi-Juei Wang, Chih-Hsuan Cancers (Basel) Review SIMPLE SUMMARY: There is a higher incidence rate of upper gastrointestinal cancer in those with liver cirrhosis. The contributing factors include gastric ulcers, congestive gastropathy, zinc deficiency, alcohol drinking, tobacco use and gut microbiota. Most of the de novo malignancies that develop after liver transplantation for cirrhotic patients are upper gastrointestinal cancers. The surgical risk of upper gastrointestinal cancers in cirrhotic patients with advanced liver cirrhosis is higher. ABSTRACT: The extended scope of upper gastrointestinal cancer can include esophageal cancer, gastric cancer and pancreatic cancer. A higher incidence rate of gastric cancer and esophageal cancer in patients with liver cirrhosis has been reported. It is attributable to four possible causes which exist in cirrhotic patients, including a higher prevalence of gastric ulcers and congestive gastropathy, zinc deficiency, alcohol drinking and tobacco use and coexisting gut microbiota. Helicobacter pylori infection enhances the development of gastric cancer. In addition, Helicobacter pylori, Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans also contribute to the development of pancreatic cancer in cirrhotic patients. Cirrhotic patients (especially those with alcoholic liver cirrhosis) who undergo liver transplantation have a higher overall risk of developing de novo malignancies. Most de novo malignancies are upper gastrointestinal malignancies. The prognosis is usually poor. Considering the surgical risk of upper gastrointestinal cancer among those with liver cirrhosis, a radical gastrectomy with D1 or D2 lymph node dissection can be undertaken in Child class A patients. D1 lymph node dissection can be performed in Child class B patients. Endoscopic submucosal dissection for gastric cancer or esophageal cancer can be undertaken safely in selected cirrhotic patients. In Child class C patients, a radical gastrectomy is potentially fatal. Pancreatic radical surgery should be avoided in those with liver cirrhosis with Child class B or a MELD score over 15. The current review focuses on the recent reports on some factors in liver cirrhosis that contribute to the development of upper gastrointestinal cancer. Quitting alcohol drinking and tobacco use is important. How to decrease the risk of the development of gastrointestinal cancer in those with liver cirrhosis remains a challenging problem. MDPI 2022-05-02 /pmc/articles/PMC9105927/ /pubmed/35565397 http://dx.doi.org/10.3390/cancers14092269 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Jeng, Kuo-Shyang
Chang, Chiung-Fang
Sheen, I-Shyan
Jeng, Chi-Juei
Wang, Chih-Hsuan
Upper Gastrointestinal Cancer and Liver Cirrhosis
title Upper Gastrointestinal Cancer and Liver Cirrhosis
title_full Upper Gastrointestinal Cancer and Liver Cirrhosis
title_fullStr Upper Gastrointestinal Cancer and Liver Cirrhosis
title_full_unstemmed Upper Gastrointestinal Cancer and Liver Cirrhosis
title_short Upper Gastrointestinal Cancer and Liver Cirrhosis
title_sort upper gastrointestinal cancer and liver cirrhosis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105927/
https://www.ncbi.nlm.nih.gov/pubmed/35565397
http://dx.doi.org/10.3390/cancers14092269
work_keys_str_mv AT jengkuoshyang uppergastrointestinalcancerandlivercirrhosis
AT changchiungfang uppergastrointestinalcancerandlivercirrhosis
AT sheenishyan uppergastrointestinalcancerandlivercirrhosis
AT jengchijuei uppergastrointestinalcancerandlivercirrhosis
AT wangchihhsuan uppergastrointestinalcancerandlivercirrhosis